Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain

NCT03181984 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

501

Enrollment

INDUSTRY

Sponsor class

Conditions

Port-Wine Stain

Interventions

DRUG: Hemoporfin

Sponsor

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.